Biomea Fusion Inc (BMEA)
12.22
-0.56
(-4.38%)
USD |
NASDAQ |
May 17, 16:00
12.22
0.00 (0.00%)
After-Hours: 20:00
Biomea Fusion Free Cash Flow (Quarterly): -32.06M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -32.06M |
| December 31, 2023 | -22.84M |
| September 30, 2023 | -23.94M |
| June 30, 2023 | -26.23M |
| March 31, 2023 | -26.95M |
| December 31, 2022 | -20.91M |
| September 30, 2022 | -16.74M |
| June 30, 2022 | -15.70M |
| March 31, 2022 | -10.09M |
| Date | Value |
|---|---|
| December 31, 2021 | -16.19M |
| September 30, 2021 | -11.03M |
| June 30, 2021 | -7.247M |
| March 31, 2021 | -4.142M |
| December 31, 2020 | -2.775M |
| September 30, 2020 | -1.114M |
| June 30, 2020 | -0.369M |
| March 31, 2020 | -0.252M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-32.06M
Minimum
Mar 2024
-0.252M
Maximum
Mar 2020
-14.03M
Average
-15.70M
Median
Jun 2022
Free Cash Flow (Quarterly) Benchmarks
| Poseida Therapeutics Inc | -15.26M |
| Cartesian Therapeutics Inc | -16.52M |
| BioXcel Therapeutics Inc | -17.71M |
| NovaBay Pharmaceuticals Inc | -1.574M |
| Palatin Technologies Inc | -8.607M |